newsfilter
← Latest News
PR Newswire·

BIOVAXYS ANNOUNCES WARRANT EXTENSION

VANCOUVER, BC, Aug. 9, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE:BIOV, FRA: 5LB, OTCQB:BVAXF) ("BioVaxys" or the "Company") announces that it has extended the expiry date of 4,483,689 share purchase warrants with an exercise price of $0.50 and